The Europe pharmaceuticals market is experiencing steady expansion, supported by increasing demand for treatments, advances in drug development, and continued investment in pharmaceutical research. According to Fortune Business Insights, the Europe pharmaceuticals market size was valued at USD 411.94 billion in 2024. The market is estimated to grow from USD 437.98 billion in 2025 to USD 728.20 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.5% during the forecast period.
The pharmaceutical industry plays an important role in addressing chronic and infectious diseases across Europe. Medicines and vaccines are used to manage a broad range of conditions, including cancer, diabetes, cardiovascular disorders, and infectious diseases. An aging population and rising healthcare needs are encouraging pharmaceutical companies to expand their research pipelines and introduce new treatment options.
Key companies operating in the Europe pharmaceuticals market include:
These companies participate in the market through pharmaceutical research, drug development, manufacturing, and commercialization. Their strategies include launching new medicines, expanding treatment portfolios, pursuing strategic collaborations, and strengthening their presence across European countries.